/Unitedhealth%20Group%20Inc%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
As we head into January 2026, investors and analysts are closely scrutinizing UnitedHealth Group (UNH) to determine whether UNH stock merits a buy, sell, or hold stance. Once a perennial outperformer in the healthcare sector, UnitedHealth has faced a challenging 2025 marked by earnings misses, revised profit guidance, elevated medical costs, and operational pressures, particularly in its Medicare Advantage business, which drove the company’s share price to significant lows and raised questions about near-term growth prospects. Yet, recent data points to stabilizing fundamentals that could underpin a rebound in 2026.
So, should you invest in UNH stock now?
